These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9801712)

  • 41. The role of antisocial and borderline personality features in substance dependence among incarcerated females.
    Chapman AL; Cellucci T
    Addict Behav; 2007 Jun; 32(6):1131-45. PubMed ID: 16962249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.
    Brooner RK; King VL; Kidorf M; Schmidt CW; Bigelow GE
    Arch Gen Psychiatry; 1997 Jan; 54(1):71-80. PubMed ID: 9006403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Patients with a diagnosis of pancreatitis and "dual diagnosis"].
    Just M; Ogłodek E
    Pol Merkur Lekarski; 2013 May; 34(203):298-301. PubMed ID: 23894784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current epidemiology of comorbidity of psychiatric and addictive disorders.
    Miller NS; Fine J
    Psychiatr Clin North Am; 1993 Mar; 16(1):1-10. PubMed ID: 8456035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual diagnosis: a model for intermediate care.
    Egan MP; Anderson B; Carrabis J
    Perspect Addict Nurs; 1994; 5(1):3-6. PubMed ID: 7712368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevention of adolescent drug abuse: implications of etiological, developmental, behavioral, and environmental models.
    Murray DM; Perry CL
    NIDA Res Monogr; 1985; 56():236-56. PubMed ID: 3929102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comorbid adolescent substance abuse: a maladaptive pattern of self-regulation.
    Horowitz HA; Overton WF; Rosenstein D; Steidl JH
    Adolesc Psychiatry; 1992; 18():465-83. PubMed ID: 1562085
    [No Abstract]   [Full Text] [Related]  

  • 48. Categorical and continuous models of liability to externalizing disorders: a direct comparison in NESARC.
    Markon KE; Krueger RF
    Arch Gen Psychiatry; 2005 Dec; 62(12):1352-9. PubMed ID: 16330723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of Severe Mental Illness Dual Diagnosis Among Inpatients in a Psychiatric Hospital in Malaysia.
    Subramaniam S; Yee A; Bin Amer Nordin AS; Bin Khalib AQ
    J Dual Diagn; 2021; 17(1):4-12. PubMed ID: 33308058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antisocial personality disorder as a confounder in PTSD and substance use disorders.
    Sule A; Kelly KI
    Am J Psychiatry; 2006 Oct; 163(10):1840; author reply 1840. PubMed ID: 17012703
    [No Abstract]   [Full Text] [Related]  

  • 51. The treatment of substance misuse in psychopathic individuals: why heterogeneity matters.
    Gudonis LC; Derefinko K; Giancola PR
    Subst Use Misuse; 2009; 44(9-10):1415-33. PubMed ID: 19938925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Walking the fine line: self-reported reasons for substance use in persons with severe mental illness.
    Pettersen H; Ruud T; Ravndal E; Landheim A
    Int J Qual Stud Health Well-being; 2013 Dec; 8():21968. PubMed ID: 24369778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using rodents to model schizophrenia and substance use comorbidity.
    Ng E; McGirr A; Wong AH; Roder JC
    Neurosci Biobehav Rev; 2013 Jun; 37(5):896-910. PubMed ID: 23567519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The epidemiology of dual diagnosis.
    Kessler RC
    Biol Psychiatry; 2004 Nov; 56(10):730-7. PubMed ID: 15556117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comorbidity of substance use with mental disorders].
    Leonidaki V; Maliori M
    Psychiatriki; 2009 Jan; 20(1):17-34. PubMed ID: 22214831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and consequences of dual diagnosis.
    Buckley PF; Brown ES
    J Clin Psychiatry; 2006 Jul; 67(7):e01. PubMed ID: 17107226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substance use disorders in schizophrenia: review, integration, and a proposed model.
    Blanchard JJ; Brown SA; Horan WP; Sherwood AR
    Clin Psychol Rev; 2000 Mar; 20(2):207-34. PubMed ID: 10721498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comorbid substance use disorder: prevalence, patterns of use, and course.
    Cuffel BJ
    New Dir Ment Health Serv; 1996; (70):93-105. PubMed ID: 8754233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [CO-OCCURRING SCHIZOPHRENIA AND SUBSTANCE USE DISORDER: ETIOLOGICAL THEORIES AND CHALLENGES IN ISRAEL].
    Florentin S; Raskin S
    Harefuah; 2017 Nov; 156(11):715-719. PubMed ID: 29198090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisocial behavior and alcoholism: a behavioral genetic perspective on comorbidity.
    Waldman ID; Slutske WS
    Clin Psychol Rev; 2000 Mar; 20(2):255-87. PubMed ID: 10721500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.